Acquisitions (Tables)

12 Months Ended

Dec. 31, 2019

Business Acquisition [Line Items]

Business Acquisition, Pro Forma Information

The following table summarizes our consolidated results of operations for the years ended December 31, 2018 and 2017, as well as unaudited pro forma consolidated results of operations as though the acquisition of the Argon critical care division had occurred on January 1, 2016 and the acquisition of Cianna Medical and Vascular Insights had occurred on January 1, 2017 (in thousands, except per common share amounts):

	2018				2017
	As Reported		Pro Forma		As Reported		Pro Forma
Net sales	$	882,753	$	928,336	$	727,852	$	768,571
Net income		42,017		20,699		27,523		(13,720)
Earnings per common share:
Basic	$	0.80	$	0.40	$	0.56	$	(0.28)
Diluted	$	0.78	$	0.38	$	0.55	$	(0.27)

Note: The pro forma results for the year ended December 31, 2019 are not included in the table above because the operating results of the Argon critical care division, Cianna Medical, and Vascular Insights acquisitions were included in our consolidated statements of income for these periods

Fibrovein Holdings Limited

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	277
Inventories		843
Prepaid expenses and other assets		49
Intangibles
Developed technology		10,428
Goodwill		4,975
Total assets acquired		16,572
Liabilities Assumed
Trade payables		(53)
Accrued expenses		(29)
Deferred income tax liabilities		(1,890)
Total liabilities assumed		(1,972)
Total net assets acquired	$	14,600

Brightwater

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	55
Inventories		349
Property and equipment		409
Other long-term assets		30
Intangibles
Developed technology		31,960
Customer lists		83
Trademarks		250
Goodwill		17,492
Total assets acquired		50,628
Liabilities Assumed
Trade payables		(58)
Accrued expenses		(261)
Other long-term obligations		(1,522)
Deferred income tax liabilities		(4,148)
Total liabilities assumed		(5,989)
Total net assets acquired	$	44,639

Vascular Insights

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Inventories	$	1,353
Intangibles
Developed technology		32,750
Customer list		840
Trademarks		1,410
Goodwill		21,832
Total net assets acquired	$	58,185

Cianna Medical

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	6,151
Inventories		5,803
Prepaid expenses and other current assets		315
Property and equipment		1,047
Other long-term assets		14
Intangibles
Developed technology		134,510
Customer lists		3,330
Trademarks		7,080
Goodwill		61,379
Total assets acquired		219,629
Liabilities Assumed
Trade payables		(1,497)
Accrued expenses		(2,384)
Other long-term liabilities		(1,527)
Deferred income tax liabilities		(25,940)
Total liabilities assumed		(31,348)
Total net assets acquired	$	188,281

DirectACCESS Medical, LLC

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Inventories	$	971
Intangibles
Developed technology		4,840
Customer list		120
Trademarks		400
Goodwill		938
Total net assets acquired	$	7,269

Becton, Dickinson and Company

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Inventories	$	5,804
Property and equipment		748
Intangibles
Developed technology		74,000
Customer list		4,200
Trademarks		4,900
In-process technology		2,500
Goodwill		9,728
Total net assets acquired	$	101,880

ITL Healthcare Pty Ltd

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	1,287
Other receivables		56
Inventories		1,808
Prepaid expenses and other assets		65
Property and equipment		1,053
Intangibles
Customer lists		5,940
Goodwill		3,945
Total assets acquired		14,154
Liabilities Assumed
Trade payables		(216)
Accrued expenses		(747)
Deferred tax liabilities		(1,901)
Total liabilities assumed		(2,864)
Total net assets acquired	$	11,290

Laurane Medical S.A.S.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Inventories	$	594
Intangibles
Developed technology		14,920
Customer list		120
Goodwill		6,366
Total net assets acquired	$	22,000

Osseon LLC

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Inventories	$	979
Property and equipment		58
Intangibles
Developed technology		5,400
Customer list		200
Goodwill		203
Total net assets acquired	$	6,840

Vascular Access Technologies, Inc.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Intangibles
Developed technology	$	7,800
In-process technology		920
Goodwill		4,281
Deferred tax liabilities		(3,101)
Total net assets acquired	$	9,900

Argon Medical Devices, Inc.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Cash and cash equivalents	$	1,436
Trade receivables		8,351
Inventories		11,222
Prepaid expenses and other assets		1,275
Income tax refund receivable		165
Property and equipment		2,319
Deferred tax assets		202
Intangibles
Developed technology		2,200
Customer lists		1,500
Trademarks		900
Total assets acquired		29,570
Liabilities Assumed
Trade payables		(2,414)
Accrued expenses		(5,083)
Deferred income tax liabilities		(934)
Total liabilities assumed		(8,431)
Total net assets acquired		21,139
Gain on bargain purchase (1)		(11,039)
Total purchase price	$	10,100
(1) The total fair value of the net assets acquired from Argon exceeded the purchase price, resulting in a gain on bargain purchase which was recorded within other income (expense) in our consolidated statements of income. We believe the reason for the gain on bargain purchase was a result of the divestiture of a non-strategic, slow-growth critical care business for Argon. It is our understanding that the divestiture allows Argon to focus on its higher growth interventional portfolio.

Catheter Connections, Inc.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Assets Acquired
Trade receivables	$	958
Inventories		2,157
Prepaid expenses and other assets		85
Property and equipment		1,472
Intangibles
Developed technology		21,100
Customer lists		700
Trademarks		2,900
Goodwill		8,989
Total assets acquired		38,361
Liabilities Assumed
Trade payables		(338)
Accrued expenses		(23)
Total liabilities assumed		(361)
Net assets acquired	$	38,000